OptimizeRx Corp. Stock Analysis & AI Score
OptimizeRx Corp. (OPRX) has an ST Score of 67.6 (B), driven by its Sentiment (A+) and held back by its Valuation (D+). Analysts rate it Buy with a $10.25 price target (+29.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
OptimizeRx Corp. (OPRX) has an ST Score of 67.6 (B), driven by its Sentiment (A+) and held back by its Valuation (D+). Analysts rate it Buy with a $10.25 price target (+29.9% upside).
- Strongest
- SentimentA+
- Weakest
- ValuationD+
All factor grades
- SentimentA+
- ProfitabilityA
- Financial StrengthB+
- GrowthB
- MomentumB-
- ForecastB-
- ValuationD+
- Piotroski7/9
Contact
OPRX stock: frequently asked questions
What is OPRX's ST Score?
OptimizeRx Corp. (OPRX) has an ST Score of 67.6 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is OPRX a buy, hold, or sell?
Analysts rate OPRX a Buy, with a price target of $10.25 (+29.9% vs the current price). Our ST Score grades it B (67.6/100). The ST Score is a data-driven signal, not a recommendation.
What are OPRX's factor grades?
Valuation D+, Profitability A, Financial Strength B+, Momentum B-, Growth B, Forecast B-, Sentiment A+.
What is OPRX's valuation grade?
OptimizeRx Corp. (OPRX) earns a valuation grade of D+, measured against Medical - Healthcare Information Services peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is OPRX's growth grade?
OptimizeRx Corp. (OPRX) earns a growth grade of B, measured against Medical - Healthcare Information Services peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is OPRX's profitability grade?
OptimizeRx Corp. (OPRX) earns a profitability grade of A, measured against Medical - Healthcare Information Services peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is OPRX's financial strength grade?
OptimizeRx Corp. (OPRX) earns a financial strength grade of B+, measured against Medical - Healthcare Information Services peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for OPRX?
The average analyst price target for OptimizeRx Corp. (OPRX) is $10.25 from 15 analysts, which is +29.9% versus the recent price of $7.89.
What is OPRX's Piotroski score?
OptimizeRx Corp. (OPRX) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.